Economic Analysis of New Single-Inhaler Triple Therapies in Patients with COPD in the UK

Economic Analysis of New Single-Inhaler Triple Therapies in Patients with COPD in the UK

Rui Cai,1 Alan A Martin,2 Yuchen Ge,3 Nancy A Risebrough,3 Katrin Haeussler,4 Christopher Compton,5 David MG Halpin,6 Afisi S Ismaila7,8 1ICON Health Economics, ICON plc, Amsterdam, the Netherlands; 2Value Evidence and Outcomes, GSK, London, UK; 3ICON Health Economics, ICON plc, Toronto, ON, Canada;...

Full description

Saved in:
Bibliographic Details
Main Authors: Cai R, Martin AA, Ge Y, Risebrough NA, Haeussler K, Compton C, Halpin DM, Ismaila AS
Format: Article
Language:English
Published: Dove Medical Press 2025-08-01
Series:International Journal of COPD
Subjects:
Chronic obstructive pulmonary disease
cost-effectiveness
fluticasone furoate/umeclidinium/vilanterol
GALAXY model
probabilistic.
Online Access:https://www.dovepress.com/economic-analysis-of-new-single-inhaler-triple-therapies-in-patients-w-peer-reviewed-fulltext-article-COPD
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.dovepress.com/economic-analysis-of-new-single-inhaler-triple-therapies-in-patients-w-peer-reviewed-fulltext-article-COPD

Similar Items